Biotech firm Acusphere says that it plans to move out of its corporate headquarters in Watertown, MA, and cut 40 jobs or about two-thirds of its workforce to conserve cash as it pursues approval of its imaging agent perflubutane polymer microspheres (Imagify) for detecting coronary artery disease. The company plans to move all of its remaining employees into its manufacturing facility in Tewksbury, MA. The firm has also filed papers with the Securities and Exchange Commission to voluntarily suspend its reporting obligations to the agency. The firm’s job cuts have been added to our Boston Layoff Tracker.
Author: Ryan McBride
Ryan is an award-winning business journalist who contributes to our life sciences and technology coverage. He was previously a staff writer for Mass High Tech, a Boston business and technology newspaper, where he and his colleagues won a national business journalism award from the Society of American Business Editors and Writers in 2008. In recent years, he has made regular TV appearances on New England Cable News.
Prior to MHT, Ryan covered the life sciences, technology, and energy sectors for Providence Business News. He graduated with honors from the University of Rhode Island in 2001 with a bachelor’s degree in communications. When he’s not chasing down news, Ryan enjoys mountain biking and skiing in his home state of Vermont.
View all posts by Ryan McBride
